Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evogene (EVGN) Depreciation & Amortization (CF) (2016 - 2024)

Historic Depreciation & Amortization (CF) for Evogene (EVGN) over the last 9 years, with Q4 2024 value amounting to $348000.0.

  • Evogene's Depreciation & Amortization (CF) fell 1674.64% to $348000.0 in Q4 2024 from the same period last year, while for Sep 2025 it was $348000.0, marking a year-over-year decrease of 7825.0%. This contributed to the annual value of $1.5 million for FY2024, which is 676.42% down from last year.
  • Evogene's Depreciation & Amortization (CF) amounted to $348000.0 in Q4 2024, which was down 1674.64% from $382000.0 recorded in Q3 2024.
  • Evogene's Depreciation & Amortization (CF)'s 5-year high stood at $496000.0 during Q2 2020, with a 5-year trough of $313000.0 in Q3 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $388900.0, with a median of $394000.0 in 2020.
  • As far as peak fluctuations go, Evogene's Depreciation & Amortization (CF) plummeted by 3533.06% in 2021, and later surged by 2779.55% in 2022.
  • Quarter analysis of 5 years shows Evogene's Depreciation & Amortization (CF) stood at $392000.0 in 2020, then fell by 19.13% to $317000.0 in 2021, then rose by 24.92% to $396000.0 in 2022, then increased by 5.56% to $418000.0 in 2023, then decreased by 16.75% to $348000.0 in 2024.
  • Its last three reported values are $348000.0 in Q4 2024, $382000.0 for Q3 2024, and $374000.0 during Q2 2024.